Clinical Trials on Fallopian Tube Carcinosarcoma in Japan
Total 24 results
-
Translational Research Center for Medical Innovation...Japanese Gynecologic Oncology Group (JGOG); Department of Obstetrics and Gynecology... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
Japanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerJapan
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruiting
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsJapan
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous... and other conditionsUnited States, Korea, Republic of, Canada, Japan
-
Hoffmann-La RocheGOG Foundation; European Network of Gynaecological Oncological Trial Groups...CompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerKorea, Republic of, United States, Italy, Belgium, Australia, France, Austria, China, Denmark, Germany, Greece, Spain, Sweden, Japan, Russian Federation, Turkey, Norway, Brazil, Czechia, Finland, Poland, Israel
-
Translational Research Center for Medical Innovation...Okayama University; Japanese Gynecologic Oncology Group (JGOG)RecruitingFallopian Tube Carcinoma | Peritoneal Carcinoma | Ovarian Carcinoma | BRCA1 and/or BRCA2 Variant CarriersJapan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Mucinous... and other conditionsUnited States, Korea, Republic of, Japan
-
Bristol-Myers SquibbEisai Inc.RecruitingNeoplasms, OvarianAustralia, United States, Korea, Republic of, Chile, Belgium, Italy, Spain, Israel, Japan
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Austria, Belgium, Italy, Netherlands, Spain, Canada, Denmark, Germany, Korea, Republic of, Russian Federation, Hong Kong, Greece, Japan
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Gynecologic Oncology Trial & Investigation ConsortiumJapanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaJapan, United States, Hong Kong, Korea, Republic of, New Zealand, Singapore
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Merck Sharp & Dohme LLCGynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerPoland, Korea, Republic of, United States, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditionsUnited States, Japan
-
AstraZenecaCompletedStomach Neoplasms | Small Cell Lung Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Triple Negative Breast Neoplasms | Esophageal Squamous Cell Carcinoma | Carcinoma, Pancreatic Ductal | Carcinoma, Squamous Cell of Head and Neck | Esophagogastric Junction NeoplasmsKorea, Republic of, Japan
-
Merck Sharp & Dohme LLCActive, not recruitingFallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian CancerUnited States, Germany, Israel, Canada, China, Australia, Belgium, Brazil, Chile, Colombia, Denmark, Finland, France, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Poland, Russian Federation, Turkey and more
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedSarcomaUnited States, Japan
-
Boston Scientific CorporationRecruitingEndoscopy | Hemostasis | Perforation Colon | Feeding Tube ComplicationUnited States, India, Hong Kong, Canada, China, Japan